Monocyte and neutrophil chemotaxis in psoriasis. Clinical and experimental studies.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Danish medical bulletin

• Publication date

  1989-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 2645091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human monocyte and neutrophil chemotaxis in vitro employing 51Cr-labelled leukocytes.

  2009cited by this paper
• Monocyte chemotaxis: a method for routine in vitro investigation using lactic dehydrogenase as a marker enzyme.

  2009cited by this paper
• Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.

  2009cited by this paper
• Separation of blood leucocytes, granulocytes and lymphocytes.

  2008cited by this paper
• Chemotactic lipoxygenase products in sera from patients with psoriasis

  2004cited by this paper
• Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes

  2004cited by this paper
• Neutrophil chemotaxis in psoriasis before and after PUVA therapy

  2004cited by this paper
• Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cells

  2004cited by this paper
• Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis

  2004cited by this paper
• Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis

  2004cited by this paper
• Phototherapy of urticaria pigmentosa: Clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes

  2004cited by this paper
• Structural aspects of initial psoriatic lesions

  2004cited by this paper
• The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products

  2004cited by this paper
• Migration-stimulating effect of psoriatic scales on polymorphonuclear leukocytes

  2004cited by this paper
• Epidermis and lymphocyte interactions during a tuberculin skin reaction

  1988cited by this paper
• Skin reflectance spectrophotometry.

  1987cited by this paper
• Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis.

  1987cited by this paper
• The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.

  1987cited by this paper
• Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes.

  1986cited by this paper
• Neutrophil chemotaxis in psoriasis.

  1986cited by this paper
• Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.

  1986cited by this paper
• Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.

  1986cited by this paper
• Intralesional injection of 15(S)-hydroxyeicosatetraenoic acid in psoriasis.

  1986cited by this paper
• Clearance of psoriasis with low dose cyclosporin.

  1986cited by this paper
• Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.

  1986cited by this paper
• Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Correlation with leukocyte chemotactic activity and C5a anaphylatoxin.

  1986cited by this paper
• Dermis-derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity.

  1986cited by this paper
• Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.

  1986cited by this paper
• Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study.

  1986cited by this paper
• Detection of leukotrienes in the serum of asthmatic and psoriatic patients.

  1986cited by this paper
• Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.

  1986cited by this paper
• The role of chemo‐attractant lipoxygenase products in the pathogenesis of psoriasis

  1985cited by this paper
• The functions of polymorphonuclear leukocytes emigrating into the skin.

  1985cited by this paper
• Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).

  1985cited by this paper
• Normalization of monocyte chemotaxis precedes clinical resolution of psoriasis treated with benoxaprofen.

  1985cited by this paper
• The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.

  1985cited by this paper
• Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.

  1985cited by this paper
• The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils

  1985cited by this paper
• Neutrophil and monocyte chemotaxis in pustulosis palmo‐plantaris and pustular psoriasis

  1985cited by this paper
• Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes.

  1985cited by this paper
• Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes

  1985cited by this paper
• The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.

  1984cited by this paper
• Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.

  1984cited by this paper
• Cyclosporin for psoriasis.

  1984cited by this paper
• Production of intraepidermal microabscesses by topical application of leukotriene B4.

  1984cited by this paper
• Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils.

  1984cited by this paper
• Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity

  1984cited by this paper
• Chemoattractant receptors on phagocytic cells.

  1984cited by this paper
• Mode of action of benoxaprofen.

  1984cited by this paper
• Effects of in vitro PUVA on human leukocyte function

  1984cited by this paper
• Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4.

  1984cited by this paper
• Benoxaprofen, a potent inhibitor of monocyte/endothelial-cell interaction.

  1984cited by this paper
• Characterization of an oligopeptide chemoattractant receptor on human blood monocytes using a new radioligand.

  1984cited by this paper
• The identification of hydroxy fatty acids in psoriatic skin.

  1983cited by this paper
• Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.

  1983cited by this paper
• NEUTROPHIL POLYMORPHONUCLEARS, MEDIATORS AND THE PATHOGENESIS OF PSORIASIS

  1983cited by this paper
• Endogenous component chemotactic assay (ECCA)

  1983cited by this paper
• The preferential inhibition of 5‐lipoxygenase product formation by benoxaprofen

  1983cited by this paper
• Cutaneous blood flow in psoriasis.

  1983cited by this paper
• Benoxaprofen improves psoriasis. A double-blind study.

  1983cited by this paper
• Human monocyte chemotaxis in vitro. Influence of in vitro variables in the filter assay.

  1983cited by this paper
• Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation

  1983cited by this paper
• Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.

  1983cited by this paper
• Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.

  1983cited by this paper
• Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis

  1983cited by this paper
• Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages

  1982cited by this paper
• Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.

  1982cited by this paper
• Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.

  1982cited by this paper
• The pharmacology of benoxaprofen with particular to effects on lipoxygenase product formation.

  1982cited by this paper
• Leukocyte chemotaxis.

  1982cited by this paper
• Earliest clinical and histological changes in psoriasis.

  1981cited by this paper
• Abnormal phagocyte chemotaxis: pathophysiology, clinical manifestations, and management of patients.

  1981cited by this paper
• Neutrophil leukocyte migration in psoriasis vulgaris.

  1981cited by this paper
• Molecular and cellular mechanisms of leukocyte chemotaxis.

  1981cited by this paper
• Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B

  1981cited by this paper
• Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis.

  1981cited by this paper
• Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.

  1981cited by this paper
• Increased superoxide generation by normal granulocytes incubated in sera from patients with psoriasis.

  1981cited by this paper
• Specificity and reversibility of chemotactic deactivation of human monocytes

  1981cited by this paper
• Inhibition of DNA replication and repair in cultured human cells by anthralin or danthron

  1981cited by this paper
• Chemotactic factor concentration gradients in chemotaxis assay systems.

  1981cited by this paper
• IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses.

  1981cited by this paper
• Enhanced monocyte and neutrophil cytotoxicity and normal cyclic nucleotide levels in severe psoriasis

  1981cited by this paper
• Effect of anthralin on stratum corneum antigenicity and polymorphonuclear leukocyte chemotaxis

  1981cited by this paper
• Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.

  1980cited by this paper
• Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species.

  1980cited by this paper
• Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis.

  1980cited by this paper
• Human-B and T-lymphocyte locomotion in response to casein, C5a, and f-met-leu-phe.

  1980cited by this paper
• The effect of methotrexate and hydroxyurea on neutrophil chemotaxis

  1980cited by this paper
• Increased chemotactic activity of neutrophil leukocytes in psoriasis

  1980cited by this paper
• Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self‐activated serum

  1980cited by this paper
• The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

  1980cited by this paper
• Limited application period for dithranol in psoriasis

  1980cited by this paper
• Increased granulocyte adherence in psoriasis and psoriatic arthritis.

  1980cited by this paper
• DNA interstrand crosslinks visualized by electron microscopy in PUVA-treated psoriasis.

  1979cited by this paper
• Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue.

  1979cited by this paper
• Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.

  1979cited by this paper
• Human monocyte chemotaxis: a quantitative in vivo technique.

  1979cited by this paper
• Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

  1979cited by this paper
• Effect of 8-methoxypsoralen plus UVA on psoriasis leukotactic factor.

  1979cited by this paper

• Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis

  2005cites this paper
• Duration of immunity in dogs after vaccination or naturally acquired infection

  2001cites this paper
• Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine.

  1999cites this paper
• Fall‐off in immunity following diphtheria revaccination ‐ an 8 year follow‐up study

  1996cites this paper
• Eicosanoid and cytokine production by human peritoneal macrophages : characterization and modulation

  1995influential citation
• Changes in Eicosanoid and Tumour Necrosis Factor-α Production by Rat Peritoneal Macrophages During Carrageenin-Induced Peritonitis

  1994cites this paper
• Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules

  1992cites this paper
• Molecular mechanism of methotrexate action in inflammation

  1992cites this paper
• 12(R)- and 12(S)-hydroxyeicosatetraenoic acids: chemistry, biology, and pharmacology.

  1989cites this paper